Literature DB >> 25586101

The messenger's great message for vaccination.

Steve Pascolo1.   

Abstract

Poly ribonucleic acid (RNA) is the only polymer capable to recapitulate all processes of life: containment of genetic information, enzymatic activities and capacity to create defined 3D structures. Since it has a remarkable chemical stability (at neutral or acidic pH) and can be modified to enhance/reduce particular features (e.g., stability in biological RNase containing milieus or recognition by immune sensors), it is a particularly versatile and ideal active pharmaceutical ingredient. However, the utilization of RNA as a gene vehicle (messenger RNA, mRNA) for therapy has only recently been exploited. Within this scope, mRNA-based vaccines designed to trigger anti-cancer, anti-virus or anti-allergy immune responses have been developed. Modifications of mRNA vectors and implementation of adequate formulations have allowed to turn this natural superlative biological molecule into a safe active pharmaceutical ingredient that can virtually address any medical need including vaccination or immunotherapy. This is the newest great message delivered by this messenger.

Entities:  

Keywords:  allergies; cancer; infections; messenger RNA; vaccine

Mesh:

Substances:

Year:  2015        PMID: 25586101     DOI: 10.1586/14760584.2015.1000871

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  7 in total

Review 1.  mRNA vaccines manufacturing: Challenges and bottlenecks.

Authors:  Sara Sousa Rosa; Duarte M F Prazeres; Ana M Azevedo; Marco P C Marques
Journal:  Vaccine       Date:  2021-03-24       Impact factor: 4.169

Review 2.  The notorious R.N.A. in the spotlight - drug or target for the treatment of disease.

Authors:  Philipp Reautschnig; Paul Vogel; Thorsten Stafforst
Journal:  RNA Biol       Date:  2016-07-14       Impact factor: 4.652

Review 3.  Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients.

Authors:  Emanuela Romano; Steve Pascolo; Patrick Ott
Journal:  J Immunother Cancer       Date:  2021-06       Impact factor: 13.751

Review 4.  Immunity to Pathogens Taught by Specialized Human Dendritic Cell Subsets.

Authors:  Jens Geginat; Giulia Nizzoli; Moira Paroni; Stefano Maglie; Paola Larghi; Steve Pascolo; Sergio Abrignani
Journal:  Front Immunol       Date:  2015-10-13       Impact factor: 7.561

5.  An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs.

Authors:  Margit Schnee; Annette B Vogel; Daniel Voss; Benjamin Petsch; Patrick Baumhof; Thomas Kramps; Lothar Stitz
Journal:  PLoS Negl Trop Dis       Date:  2016-06-23

6.  Strategies for simultaneous and successive delivery of RNA.

Authors:  Hanieh Moradian; Andreas Lendlein; Manfred Gossen
Journal:  J Mol Med (Berl)       Date:  2020-11-04       Impact factor: 4.599

7.  High resolution biosensor to test the capping level and integrity of mRNAs.

Authors:  Ignacio Moya-Ramírez; Clement Bouton; Cleo Kontoravdi; Karen Polizzi
Journal:  Nucleic Acids Res       Date:  2020-12-16       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.